Inotuzumab Ozogamicin in Individuals with Down Syndrome and Acute Lymphoblastic Leukemia.

Authors

• Amanda M Li
• Catherine Aftandilian
• Colleen Annesley
• Susan Colace
• Kelly E. Faulk
• Joshua W. Goldman
• Erin Guest
• Ammar Hayani
• Richard Ho
• Troy C. Quigg, Corewelll health West

Document Type

Article

Publication Date

6-2026

Publication Title

Leukemia

Recommended Citation

Li AM, Aftandilian C, Annesley C, Colace S, Faulk KE, Goldman JW, et al. [Quigg TC]. Inotuzumab ozogamicin in individuals with Down syndrome and acute lymphoblastic leukemia. Leukemia. 2026. doi: 10.1038/s41375-026-02997-0. PMID: 42236968.

Comments

Helen DeVos Children's Hospital

DOI

10.1038/s41375-026-02997-0

ISSN

1476-5551

PubMed ID

42236968